IP Verse

Use Of Trl Agonist And Anti-Cd47 Agent To Enhance Phagocytosis Of Cancer Cells - EP3656443B1

PatentPatent Analysis

EP3656443

THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Application Number
EP19197485A
Filing Date
Jan 21, 2016
Status
Granted And Under Opposition
Aug 27, 2021
Grant Date
Sep 29, 2021
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4069368B1
EP3341015B2
EP3147295B2

Bibliography

The patent EP3656443B1 was granted to The Board OF Trustees OF The Leland Stanford Junior University on Sep 29, 2021 following the initial filing on Jan 21, 2016 under the application number EP19197485A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

GENMABJun 29, 2022ADMISSIBLE
PFIZERJun 29, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents